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Trauma exposure and endothelial function among midlife women
Rebecca C. Thurston, PhD,1,2,3 Emma Barinas-Mitchell, PhD,2 Roland von Ka¨nel, MD,4
Yuefang Chang, PhD,5 Karestan C. Koenen, PhD,6 and Karen A. Matthews, PhD1,2,3
Abstract
Objective: Trauma is a potent exposure that can have implications for health. However, little research has
considered whether trauma exposure is related to endothelial function, a key process in the pathophysiology of
cardiovascular disease (CVD). We tested whether exposure to traumatic experiences was related to poorer
endothelial function among midlife women, independent of CVD risk factors, demographic factors, psychosocial
factors, or a history of childhood abuse.
Methods: In all, 272 nonsmoking perimenopausal and postmenopausal women aged 40 to 60 years without
clinical CVD completed the Brief Trauma Questionnaire, the Child Trauma Questionnaire, physical measures, a
blood draw, and a brachial ultrasound for assessment of brachial artery flow-mediated dilation (FMD). Relations
between trauma and FMD were tested in linear regression models controlling for baseline vessel diameter,
demographics, depression/anxiety, CVD risk factors, health behaviors, and, additionally, a history of childhood
abuse.
Results: Over 60% of the sample had at least one traumatic exposure, and 18% had three or more exposures. A
greater number of traumatic exposures was associated with lower FMD, indicating poorer endothelial function in
multivariable models (beta, b [standard error, SE] 1.05 [0.40], P¼ 0.01). Relations between trauma exposure and
FMD were particularly pronounced for three or more trauma exposures (b [SE] 1.90 [0.71], P¼ 0.008, relative to
no exposures, multivariable).
Conclusions: A greater number of traumatic exposures were associated with poorer endothelial function.
Relations were not explained by demographics, CVD risk factors, mood/anxiety, or a by history of childhood abuse.
Women with greater exposure to trauma over life maybe at elevated CVD risk.
Key Words: Cardiovascular diseases – Endothelial dysfunction – Flow-mediated Dilation – Trauma –
Women.
C
ardiovascular diseases (CVDs) are the leading cause
of death in women.1 Psychosocial factors are
increasingly appreciated to be important to the devel-
opment of CVD.2,3 One potent psychosocial exposure is
trauma. Exposure to trauma is particularly prevalent among
women. For example, the National Institute of Justice’s
National Violence Against Women Survey indicated a life-
time incidence of assault of 51.1% among US women,4 and
the Centers for Disease Control and Prevention report that
43.9% of women will experience sexual violence during their
lifetime.5
While trauma is a well-established risk factor for mental
health problems, emerging data indicate its potential impor-
tance to the development of chronic disease. Some data
indicate that a history of trauma exposure may be associated
with increased risk for CVD.6-11 However, there are several
limitations to this work. Most existing work considers self-
reported CVD outcomes, findings which are limited by
potential biases in CVD event detection and reporting.12,13
Use of subclinical CVD measures among women who do not
yet have clinical CVD can address this limitation. In fact, use
of subclinical CVD indices is important when studying mid-
life women, among whom rates of clinical CVD are low.14,15
One measure of the vasculature indexes the vascular endo-
thelium, the single cell layer lining the vessel critical to
multiple aspects of vascular health and function. Endothelial
injury and dysfunction is an initiating event in atherosclero-
sis,16 and measures of endothelial function are prospectively
associated with later CVD.17 Finally, as opposed to inquiring
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about trauma among individuals with CVD, investigation of
the trauma-CVD risk association in individuals who have not
yet experienced a CVD event is important, as the CVD event
itself can represent a traumatic exposure.6,18,19
Among nonsmoking midlife women free of clinical CVD,
we tested whether women with more traumatic exposures
over life would have poorer endothelial function at midlife.
We hypothesized that associations between trauma exposure
and endothelial dysfunction would persist controlling for
critical factors, including standard and novel CVD risk fac-
tors, depressed mood, and anxiety. Given documented rela-
tions of a history of childhood abuse with CVD risk20,21 and
relations of a history of childhood abuse with risk for later
adult trauma exposure,22 we also consider the role of a history
of childhood abuse in associations between trauma exposure
and endothelial function at midlife.
METHODS
Study sample
We recruited 304 late perimenopausal (2-12 months amenor-
rhea) and postmenopausal (12 months amenorrhea)23 non-
smoking women aged 40 to 60 years from the surrounding
community (Pittsburgh, PA). As women were recruited into a
study on hot flashes, by design, half of the women reported daily
hot flashes, and half reported no hot flashes in the past 3 months
(for further details on study design and sample characteristics,
see24). Exclusion criteria included hysterectomy and/or bilateral
oophorectomy; history of heart disease, stroke, arrhythmia,
gynecological cancer, pheochromocytoma, pancreatic tumor,
kidney failure, seizures, Parkinson’s disease, Raynaud’s phe-
nomenon; current pregnancy; or having used the following
medications in the past 3 months: oral/transdermal estrogen
or progesterone, selective estrogen receptor modulators, selec-
tive serotonin reuptake inhibitors, serotonin norepinephrine
reuptake inhibitors, gabapentin, insulin, beta blockers, calcium
channel blockers, alpha-2 adrenergic agonists, or other antiar-
rhythmic agents. Women who were undergoing chemotherapy,
hemodialysis, or peritoneal dialysis were also excluded.
Of the 304 women, 32 women were excluded due to
missing flow-mediated dilation (FMD) data because of poor
scan quality or movement during the examination. Excluded
women did not differ on any study variables than included
women. In all, 272 women were included in primary models.
Design and procedures
Women were recruited from the community via advertise-
ments, mailings, and online message boards. Participants
underwent physical measurements, ambulatory monitoring,
a blood draw, and a carotid artery ultrasound. Procedures were
approved by the University of Pittsburgh Institutional Review
Board. Participants provided written, informed consent.
Measures
Trauma and abuse exposure
Trauma exposure in adulthood was assessed via items from
the Brief Trauma Questionnaire developed for the Nurses’
Health Study II (NHS II),25 which was adapted from the Brief
Trauma Interview.26,27 This brief self-report questionnaire is
designed to assess a history of traumatic events, and the version
administered in the present study included nine items querying
about the following specific events rated as yes or no having ever
occurred: serious accidents, natural disasters, life-threatening
illness, being beaten or mugged, unwanted sexual contact, death
of a child, sexual harassment, threat of injury or violence, or
witnessing a severe injury or death. As reported by Koenen et
al,25 inter-rater reliability for the presence of criterion A1 trauma
exposure according to the Diagnostic and Statistical Manual of
Mental Disorders, 4th Edition (DSM-IV) was high (average
kappa¼ 0.70 [range 0.74-1.00] for all events, except illness
[0.60]). Exposures were considered separately, and also
summed, with the sum categorized as none, 1 to 2, or 3 or more
exposures.
Child abuse history was assessed via a separate questionnaire,
the 28-item Child Trauma Questionnaire (CTQ), a validated
measure of child abuse and neglect experienced at or before age
18.28 It included questions about emotional abuse, physical
abuse, sexual abuse, emotional neglect, physical neglect. The
CTQ has strong test-retest reliability (0.79-0.86), internal con-
sistency (a¼ 0.75–0.94), andconvergent validity.28,29TheCTQ
was considered as a total continuous scale score.
Brachial ultrasound
After an overnight fast, FMDwasmeasured after 10minutes
of supine rest by high-resolutionB-mode ultrasound imaging of
the right brachial artery, 2 to 10 cm proximal to the antecubital
crease, by trained sonographers using a standardized protocol.
Images were obtained at rest (baseline) and after 5minutes of
forearm blood flow occlusion (postdeflation) with a pneumatic
tourniquet set to 50mm Hg above the participant’s systolic
blood pressure (SBP). For baseline diameters, digitized images
were recorded for 20 seconds. Immediately after deflation,
images were recorded continuously for 3minutes. The arterial
diameterwasmeasured as the distance between the anterior and
posterior arterial wall media-adventitia interfaces on images
captured on the R wave using edge-detection software. All
images for this study were read by a single trained reader using
the Brachial Analysis System (MIA, University of Iowa)
software.30 The reading software allows continuous tracking
of the brachial artery diameter across these images so that the
peak change in diameter can be accurately determined. FMD
was calculated as themaximumpercentage of change in arterial
diameter, relative to baseline. This methodology at this labora-
tory has shown reproducibility (intraclass correlation coef-
ficient¼ 0.70-0.72).31
Covariates
Height and weight were measured via a fixed stadiometer
and a calibrated balance beam scale, and body mass index
(BMI) calculated (kg/m2). Seated blood pressure (BP) was
measured via a Dinamap device after 10-minute rest. Women
reported a lifetime history of a range of psychiatric disorders,
including post traumatic stress disorder (PTSD). Medical and
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reproductive history was assessed by standard instruments.
Menopausal status was obtained from reported menstrual
bleeding patterns.23 Parity was classified by the total reported
number of live births. Use of medications (antidepressants,
antihypertensives, lipid-lowering, glucose-lowering, beta
agonists, anticonvulsants) was reported. Anxiety was assessed
via the State-Trait Anxiety Inventory,32 depressive symptoms
by the Center for Epidemiologic Studies Depression scale,33
perceived stress via the Cohen perceived stress scale,34 and
sleep quality via the Pittsburgh Sleep Quality Index.35 Lei-
sure-time physical activity was assessed via the International
Physical Activity Questionnaire.36 Hot flashes were assessed
by 24-hour ambulatory physiologic monitoring.24 Sleep time
was assessed over 3 days via actigraphy (Actiwatch 2,
Respironics, Inc., Murrysville, PA) in 1-minute epochs, and
analyzed and scored (Philips Actiware v6.0.0 software)
according to established methods.37 Total sleep time was
calculated as: ([time in bed] [sleep onset laten-
cy] [minutes of wakefulness between sleep onset time
and final wake time]). Glucose, high-density lipoprotein
cholesterol (HDL-C), and triglycerides were measured enzy-
matically (Vital Diagnostics, Lincoln, RI; intra-assay and
inter-assay coefficients of variation [CVs], respectively, were:
glucose—1.9%, 2.4%; HDL—1.8%, 2.6%; triglycerides—
1.8%, 3.7%). Total cholesterol was determined enzymatically
(intra-assay and inter-assay CVs: 3.5% and 6.7%) and low-
density lipoprotein (LDL-C) was calculated using the Frie-
dewald formula.38 Insulin was measured via radioimmunoas-
say (intra-assay and inter-assay CVs: 4.8% and 10.5%).
Homeostatic model assessment (HOMA), reflecting insulin
resistance, was calculated.39 C-reactive protein (CRP) was
assessed using a high sensitivity reagent set (Beckman Coul-
ter, Brea, CA; intra-assay and inter-assay CVs: 5.5% and
3.0%). Interleukin (IL)-6 was assessed with an R&D Systems
high sensitivity ELISA (Minneapolis, MN; intra-assay and
inter-assay CVs: 9.1% and 10.2%).
Data analysis
Sum of trauma exposures, HOMA, triglycerides, CRP, and
IL-6 values were natural log-transformed and leisure time
physical activity square root-transformed for analysis. Differ-
ences between participants by included/excluded status were
tested using linear regression, Wilcoxon rank-sum, and chi-
square tests. Associations between trauma exposure and FMD
were tested in linear regression models. Covariates were
factors associated with FMD at P< 0.20: baseline lumen
diameter, age, race/ethnicity, leisure time physical activity,
state anxiety, parity, beta agonist medications. BMI and SBP
were forced into models. To test the role of childhood abuse in
relations between lifetime trauma exposure and FMD, a
separate set of models included CTQ scores as an additional
covariate in multivariable models testing relations between
Brief Trauma Questionnaire scores in relation to FMD. We
also tested interactions between CTQ scores and Brief
Trauma Questionnaire scores in relation to FMD in multivar-
iable models. In secondary models, a reported history of
PTSD (six women) was considered as an additional covariate
or as an exclusion. Additional covariates were education,
financial strain, depressive symptoms, perceived stress, anti-
depressants, general self-rated health, lipids, HOMA, BP-
lowering, lipid-lowering, and diabetes medications, hot
flashes, CRP, and IL-6. Residual analysis and diagnostic plots
were conducted to verify model assumptions. Analyses were
performed with SAS v9.2 (SAS Institute, Cary, NC). Models
were two-sided at a¼ 0.05.
RESULTS
Participants were on average 54 years old, postmenopausal,
overweight, and white (Table 1). The mean (SD) FMD was
7.39% (4.04). Over 60% (n¼ 164) of the sample had at least
one traumatic exposure. Eighteen percent of the women had
three or more traumatic exposures (Table 2). The most
common exposure was unwanted sexual contact, reported
by 22% of the women.
Women with a greater number of traumatic exposures,
particularly three or more, had lower FMD—an indicator
of poorer endothelial function (Table 3; Fig. 1). The single
exposure most strongly associated with lower FMD was
having a history of a major accident. Associations were not
explained by covariates associated with FMD. We also con-
sidered a range of additional covariates, including educational
attainment, additional CVD risk factors, and additional car-
diovascular medications, and relations persisted.
We considered the role of childhood abuse in these rela-
tions. As expected, the correlation between a history of trauma
exposure (Brief Trauma Questionnaire score) and childhood
abuse (CTQ score) was moderate and statistically significant
(r¼ 0.26, P< 0.0001). When including childhood abuse
history in multivariable models of lifetime trauma exposure
in relation to FMD, associations between lifetime trauma and
FMD persisted (Table 3). There was no evidence of a synergy
between child abuse and lifetime trauma exposure, as inter-
actions between trauma exposure and childhood abuse in
relation to FMD were not significant (P> 0.20).
We conducted several additional analyses. We considered
additional covariates of depressive symptoms, perceived
stress, hot flashes, self-rated health, financial strain, alcohol
use, sleep, and inflammatory markers (CRP, IL-6), and find-
ings were unchanged (data not shown). Six women reported a
history of PTSD. To consider whether findings were driven by
these women with PTSD, we first included PTSD as an
additional covariate, and next alternatively excluded women
with PTSD, and findings remained (data not shown). We
considered any differences in relations between trauma expo-
sure and FMD by race/ethnicity; interactions were not signif-
icant (interaction P> 0.10). Given prior evidence of
modification of relations of trauma exposure and cardiovas-
cular outcomes by sleep time,40 we additionally explored
whether sleep time modified associations between trauma
exposure and FMD. We found indication of interaction
between accident history and actigraphy-assessed sleep time
(interaction P¼ 0.03), with relations between accident history
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and lower FMD particularly pronounced among women
sleeping <6 hours per night (<6 hours: b¼2.87,
SE¼ 1.17, P¼ 0.02; 6 hours: b¼1.36, SE¼ 0.72,
P¼ 0.06).
DISCUSSION
In this sample of nonsmoking midlife women free of
clinical CVD, women with a history of trauma exposure,
particularly three or more traumatic exposures, had lower
FMD, indicating poorer endothelial function. Associations
between trauma exposure and endothelial function were not
explained by multiple potentially confounding or explana-
tory factors, including psychosocial or demographic factors,
mood, anxiety, CVD risk factors, or even a history of
childhood abuse or neglect. These data support the im-
portance of considering trauma exposure as an important
psychosocial factor in midlife women’s cardiovascular
health.
Prior work has linked trauma exposure to reported cardio-
vascular outcomes.9,41 The present finding is novel in its use
of vascular ultrasound measures of endothelial function
among individuals free of CVD. Use of vascular ultrasound
provides a subclinical disease marker and can indicate poten-
tial early vascular dysfunction before clinical disease is
present. Considering subclinical indicators is useful for index-
ing aspects of cardiovascular health among midlife women,
who typically show clinical CVD only decades later.1,14
Further, using subclinical measures among an asymptomatic
population avoids potential biases associated with self-
reported CVD (eg, contact with the medical system, health
literacy),12,13 and provides the opportunity for intervention
and prevention before frank disease is present. Finally, inves-
tigating subclinical CVD before clinical CVD is evident
avoids the potentially interpretative difficulty of the clinical
CVD event itself (eg, heart attack, stroke) serving as a
trauma.19 In sum, the present data underscore the importance
of particular prevention efforts aimed at women with a history
of multiple traumatic exposures, and this work may also point
to a possible mechanism, endothelial dysfunction, linking
trauma exposure to later clinical CVD.
Over 60% of the women in this study reported exposure to
one or more traumatic experiences, and 18% of the women
endorsed three or more traumatic exposures. These figures are
consistent with other work.9 Women with a greater number of
exposures had the lowest FMD, pointing to the importance of
multiple lifetime exposures.41 The most common exposure
was a history of sexual assault, reported by 22% of the
women, yet the exposure most strongly related to endothelial
function was having been in an accident (18% of the sample).
We considered an explanatory factor of ongoing physical
health issues in these relations, yet associations persisted with
adjustment for a range of physical health measures, including
TABLE 2. Prevalence of exposure to traumatic events
N (%)
Have you ever. . .
Been in a serious car accident or a serious accident? 49 (18.01)
Been in a major natural or human made disaster? 26 (9.56)
Had a very serious or life-threatening illness? 17 (6.25)
Been attacked, beaten or mugged by anyone? 53 (19.49)
Been made or pressured into having some type
of unwanted sexual contact?
60 (22.06)
Experienced the death of one of your own children? 18 (6.62)
Experienced sexual harassment at work that was
either physical or verbal?
53 (19.49)
Been in any other situation in which you were
seriously injured?
37 (13.6)
Witnessed a situation in which someone was seriously
injured or killed?
58 (21.32)
Sum exposures
0 108 (39.71)
1-2 114 (41.91)
3þ 50 (18.38)
TABLE 1. Sample characteristics
Trauma exposure
Yes (n¼ 164) No (n¼ 108)
Age, M (SD) 54.13 (3.94) 54.00 (3.93)
Race, n (%)
White 119 (72.56) 79 (73.15)
African American, Hispanic, other 45 (27.44) 29 (26.85)
BMI, M (SD) 28.57 (6.30) 29.74 (7.52)
SBP, mm Hg, M (SD) 120.6 (15.25) 117.8 (12.83)
DBP, mm Hg, M (SD) 70.31 (9.32) 69.38 (8.62)
HDL, M (SD) 62.64 (15.54) 62.86 (13.48)
LDL, M (SD) 131.5 (34.27) 130.4 (33.19)
Triglycerides, M (SD) 113.52 (66.62) 103.21 (44.13)
HOMA, M (SD) 2.67 (1.61) 2.68 (1.70)
Parity, Median (IQR) 2.0 (1, 3) 2.0 (1, 3)
Self-rated health, n (%)
Excellent 40 (24.39) 31 (38.70)
Very good 70 (42.68) 52 (48.15)
Good/fair/poor 54 (32.93) 25 (23.15)
Education, n (%)
High school, vocational school 63 (38.41) 51 (47.22)
College education or higher 101 (61.59) 57 (52.78)
Financial strain (yes), n (%) 51 (31.10) 32 (29.63)
Physical activity, leisure time,
IPAQ, M (SD)
786.76 (1113.16) 982.03 (1135.28)
State anxiety (Speilberger), M (SD) 32.18 (10.04) 32.24 (9.66)
Depressive symptoms (CESD), M (SD) 8.24 (8.37) 7.26 (7.89)
Perceived stress, M (SD) 4.59 (2.95) 4.42 (2.80)
Childhood abuse/neglect (CTQ score),
M (SD)
39.86 (14.78) 32.76 (9.92)
Hot flashes, physiologic, number/24 h,
M (SD)
9 (9) 8 (8)
CRP, M (SD) 2.89 (3.48) 3.05 (3.86)
IL-6, M (SD) 1.99 (1.83) 2.04 (2.82)
Medications, n (%)
BP-lowering 23 (14.02) 22 (20.37)
Lipid-loweringa 15 (9.15) 21 (19.44)
Diabetes 6 (3.66) 4 (3.70)
Beta-agonist 7 (4.27) 7 (9.48)
Anticonvulsants 3 (1.83) 0 (0.00)
Antidepressants 3 (1.83) 3 (2.78)
Depressive symptoms, triglycerides, HOMA, IL-6, CRP log-transformed,
physical activity square root-transformed for comparison.
BMI, body mass index; BP, blood pressure; CESD, Center for
Epidemiologic Studies Depression Scale; CRP, C-reactive protein;
CTQ, Child Trauma Questionnaire; DBP, diastolic blood pressure;
HDL, high-density lipoprotein; HOMA, homeostatic model assessment;
IL-6, interleukin 6; IPAQ, International Physical Activity Questionnaire;
IQR, interquartile range; LDL, low-density lipoprotein; M, mean;
SBP, systolic blood pressure; SD, standard deviation.
aDiffers between trauma exposure group at P< 0.05.
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self-rated health, health status, and markers of inflammation.
It is notable that women with a history of major illness in the
present study did not have lower FMD than their counterparts
without such a history. In sum, the present work indicates
that a greater number of traumatic exposures was related to
lower FMD.
A notable aspect of the current work was our consideration
of both lifetime trauma exposure and child abuse/neglect. Our
prior work has found a history of child abuse and neglect
associated with greater adult carotid atherosclerosis.20 How-
ever, controlling for childhood trauma exposure, assessed via
a validated child trauma inventory, did not reduce associa-
tions between trauma and FMD. Further, we found no evi-
dence of an interactive or additive effect of childhood and
lifetime trauma in relation to FMD. Findings support an
independent association between adult exposures from child-
hood exposures in relation to CVD risk.
We considered a range of possible confounders and path-
ways that might account for associations between trauma
exposure and endothelial function. Controlling for multiple
traditional and novel CVD risk factors, comorbidities, and
medications did not explain associations. Controlling for
depression, anxiety, and other negative affective symptoms
did not reduce associations between trauma exposure and
endothelial function, suggesting that the trauma exposure
itself was important irrespective of an ongoing affective
response to it. Excluding women endorsing a history of PTSD
did not alter findings, supporting findings consistent with
other work indicating relations between trauma exposures to
health outcomes independent of PTSD.9,41 Finally, neither hot
flashes or sleep characteristics explained associations
between trauma exposure and FMD. However, there was
some evidence that relations between accident history and
lower FMD was particularly prominent among women with
shorter sleep—a finding broadly consistent with our prior
work.40 Although many pathways were considered here,
pathways deserving further investigation in future work
include the hypothalamic pituitary adrenal axis,42 the nitric
oxide pathway,43 and epigenetic alterations,44,45 mechanisms
potentially impacted by traumatic experiences and associated
with CVD risk.
TABLE 3. Relation between trauma exposure and FMD
FMD (%) B (SE)
Model 1 Model 2 Model 3
Serious accident 1.65 (0.59)a 1.61 (0.62)b 1.78 (0.60)a
Disaster 1.27 (0.78) 1.25 (0.81) 1.17 (0.79)
Serious illness 0.41 (0.95) 0.31 (0.98) 0.36 (0.95)
Attacked 0.58 (0.57) 0.75 (0.60) 0.74 (0.60)
Sexual assault 0.48 (0.55) 0.44 (0.57) 0.69 (0.59)
Death of child 1.22 (0.91) 1.23 (0.94) 1.58 (0.95)c
Sexual harassment 0.66 (0.57) 0.76 (0.60) 0.95 (0.60)
Serious injury 0.41 (0.66) 0.42 (0.68) 0.22 (0.70)
Witness violence 0.24 (0.55) 0.27 (0.57) 0.48 (0.58)
Any exposure 0.84 (0.47)c 0.88 (0.49)c 1.03 (0.49)b
Sum exposuresd 0.73 (0.37)b 0.75 (0.39)b 1.05 (0.40)a
Number of exposurese
1-2 0.64 (0.51) 0.67 (0.53) 0.75 (0.51)
3þ 1.30 (0.64)b 1.37 (0.68)b 1.90 (0.71)a
Each exposure considered in separate model.
Model 1: Baseline diameter, age, race, BMI, SBP, beta agonist medications, anticonvulsant medications, parity, leisure time physical activity, state
anxiety.
Model 2: Model 1 covariatesþ education, diabetes, HOMA, lipids (LDL, HDL, triglycerides), additional medications (antihypertensive, lipid-lowering,
antidiabetic, antidepressant).
Model 3: Model 1 covariatesþ child trauma history (child trauma questionnaire).
BMI, body mass index; FMD, flow-mediated dilation; HDL, high-density lipoprotein; HOMA, homeostatic model assessment; LDL, low-density
lipoprotein; SBP, systolic blood pressure; SE, standard error.
aP< 0.01.
bP< 0.05.
cP< 0.10.
dLog-transformed for analysis.
eRelative to no exposures.
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FIG. 1. Adjusted mean FMD by number of traumatic exposures. Means
adjusted for baseline diameter, age, race, BMI, SBP, beta agonist
medications, anticonvulsant medications, parity, leisure time physical
activity, state anxiety. P< 0.05 relative to no exposure. BMI, body mass
index; FMD, flow-mediated dilation; SBP, systolic blood pressure.
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Several limitations deserve mention. We assessed a range
of potential exposures using an adapted measure implemented
in other major cohort studies (Nurses’ Health Study II).
However, not all possible exposures were assessed, and an
abbreviated version of this measure was administered (eg,
excluding items pertaining to nursing practice). Thus, some
misclassification of exposure is possible. Further, women
were recalling these exposures rather than assessing them
prospectively; thereby these reports may be subject to poten-
tial for influences of memory. Further, women reported a
history of PTSD, but not all PTSD symptoms were assessed,
and PTSD history was not established via diagnostic inter-
view. Although a wide range of possible confounders were
assessed and considered carefully, residual confounding is a
consideration in observational studies, and this study cannot
establish directionality or causality. Further, brachial ultra-
sound is a validated measure of endothelial function highly
correlated with coronary endothelial function46; it is not a
direct measure, which would require more invasive proce-
dures not amenable to a sample of this size. Finally, the
sample included women and had somewhat limited racial
ethnic diversity; men and more racially/ethnically diverse
samples should be considered in future work.
This study had several strengths. This study included a
well-characterized sample of nonsmoking midlife women
free of clinical CVD. Vascular endothelial function was
assessed via a widely used and validated marker of vascular
endothelial function. Multiple possible confounders and
mechanisms were measured and considered here. Exposures
during both adulthood and childhood were assessed and
considered.
CONCLUSIONS
In summary, women with a history of three or more lifetime
traumatic exposures had poorer endothelial function than
women without a trauma history. The most prevalent expo-
sure was sexual assault, yet the most potent single exposure
for endothelial function was a history of having been in an
accident. Relations were not explained by psychological
factors such as anxiety or depressive symptoms, standard
CVD risk factors, general health status, or a childhood history
of abuse or neglect. These data underscore the potential value
of considering trauma exposure as an important cardiovascu-
lar health issue among women.
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